Search research articles
Contact Us
Filters
Showing results (271-280 of 584) with videos related to
Page
of 59
Sort By:
British Journal of Haematology
|
September 9, 2014
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial
Tim H Brümmendorf, Jorge E Cortes, Cármino Antonio de Souza, et al.
Revista De Neurologia
|
September 21, 2018
[Meningeal syndrome in a patient treated with a combination of immune checkpoint inhibitors for a metastatic melanoma]
O Y Bello-Chavolla, J E Cortes-Arroyo, A Vargas-Vazquez, et al.
Blood
|
August 17, 2006
EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation
Jingxuan Pan, Alfonso Quintás-Cardama, Hagop M Kantarjian, et al.
Leukemia & Lymphoma
|
December 7, 2020
Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience
Rita Assi, Hagop Kantarjian, Michael Keating, et al.
American Journal of Hematology
|
May 20, 2016
Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034
Neil P Shah, Philippe Rousselot, Charles Schiffer, et al.
Leukemia
|
May 2, 2015
Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors
W Wang, J E Cortes, P Lin, et al.
Haematologica
|
November 8, 2011
Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients
Aref Al-Kali, Sergej Konoplev, Erpei Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment
Roland B Walter, Megan Othus, Gautam Borthakur, et al.
Cancer
|
February 6, 2014
Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemia
Katja Karjalainen, Renata Pasqualini, Jorge E Cortes, et al.
International Journal of Biological Macromolecules
|
March 30, 2025
Antimicrobial and antifungal edible coatings with ZnO nanoparticles dispersed in a chitosan-guar gum matrix for hass avocado preservation
G Chavez-Esquivel, D Ángeles-Beltrán, P M Tellez de la Torre, et al.
Page
of 59
Search research articles
Search
Showing results (271-280 of 584) with videos related to
Sort By:
Page
of 59
British Journal of Haematology
|
September 9, 2014
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial
Tim H Brümmendorf, Jorge E Cortes, Cármino Antonio de Souza, et al.
Revista De Neurologia
|
September 21, 2018
[Meningeal syndrome in a patient treated with a combination of immune checkpoint inhibitors for a metastatic melanoma]
O Y Bello-Chavolla, J E Cortes-Arroyo, A Vargas-Vazquez, et al.
Blood
|
August 17, 2006
EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation
Jingxuan Pan, Alfonso Quintás-Cardama, Hagop M Kantarjian, et al.
Leukemia & Lymphoma
|
December 7, 2020
Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience
Rita Assi, Hagop Kantarjian, Michael Keating, et al.
American Journal of Hematology
|
May 20, 2016
Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034
Neil P Shah, Philippe Rousselot, Charles Schiffer, et al.
Leukemia
|
May 2, 2015
Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors
W Wang, J E Cortes, P Lin, et al.
Haematologica
|
November 8, 2011
Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients
Aref Al-Kali, Sergej Konoplev, Erpei Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment
Roland B Walter, Megan Othus, Gautam Borthakur, et al.
Cancer
|
February 6, 2014
Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemia
Katja Karjalainen, Renata Pasqualini, Jorge E Cortes, et al.
International Journal of Biological Macromolecules
|
March 30, 2025
Antimicrobial and antifungal edible coatings with ZnO nanoparticles dispersed in a chitosan-guar gum matrix for hass avocado preservation
G Chavez-Esquivel, D Ángeles-Beltrán, P M Tellez de la Torre, et al.
Page
of 59